Zobrazeno 1 - 10
of 461
pro vyhledávání: '"M. G. WIENTJES"'
Advances in molecular medicine have led to identification of worthy cellular and molecular targets located in extracellular and intracellular compartments. Effectiveness of cancer therapeutics is limited in part by inadequate delivery and transport i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::793396741f9fddac8263f090f28ce960
https://europepmc.org/articles/PMC4829347/
https://europepmc.org/articles/PMC4829347/
Autor:
Lee G; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea., Kim SJ; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea., Park JK; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.; KI for Health Science and Technology, KAIST Institutes (KI), 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.; KI for Nanocentury, KAIST Institutes (KI), 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
Publikováno v:
Advanced healthcare materials [Adv Healthc Mater] 2024 Sep; Vol. 13 (22), pp. e2303716. Date of Electronic Publication: 2024 Jun 14.
Nanotechnology is widely used in cancer research. Models that predict nanoparticle transport and delivery in tumors (including subcellular compartments) would be useful tools. This study tested the hypothesis that diffusive transport of cationic lipo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c28136096f23d1a0ea6ded86dfb46973
https://europepmc.org/articles/PMC4169740/
https://europepmc.org/articles/PMC4169740/
Publikováno v:
Cancer Chemotherapy and Pharmacology. 44:241-248
Purpose: We have previously shown that paclitaxel, when dissolved in water and instilled into the bladder, readily penetrates the urothelium. The FDA-approved formulation uses Cremophor and ethanol to dissolve paclitaxel. In the present study, the ef
Publikováno v:
Pharmaceutical Research. 16:170-173
Publikováno v:
Cancer Chemotherapy and Pharmacology. 42:177-182
We have previously reported incomplete cytotoxic responses of other human solid tumors (bladder, head and neck, ovarian and prostate) to paclitaxel. This finding is qualitatively different from the nearly complete response observed in monolayer cultu
Publikováno v:
Pharmaceutical Research. 15:1760-1766
Purpose. We have shown that the three human prostate xenograft tumors, i.e. the androgen-dependent CWR22 tumor, and the androgen-resistant CWR22R and CWR91 tumors, are comparable to patient tumors in their expression of prostate specific antigen, mul
Publikováno v:
Cancer Chemotherapy and Pharmacology. 41:69-74
Purpose: The goal of this study was to determine whether paclitaxel, when given by a 2-h treatment, produces significant cytotoxic effects in human bladder transitional cell carcinoma and hence qualifies as a candidate drug for intravesical treatment
Publikováno v:
Pharmaceutical Research. 14:337-344
Purpose. The goal of this study was to develop physiologically based pharmacokinetic (PBPK) models for 2′,3′-dideoxyinosine (ddI) in rats when the drug was administered alone (ddI model) and with pentamidine (ddI + pentamidine model), and to use
Publikováno v:
Cancer Chemotherapy and Pharmacology. 37:539-546
The bladder wall penetration kinetics of intravesical doxorubicin were examined in radical cystectomy patients, to provide insight into drug concentrations at target tumor sites. The dosing solution (40 mg/20 ml) was instilled just prior to the start